Inflammatory myofibroblastic tumor

Inflammatory myofibroblastic tumor (IMT) is a rare type of tumor that can occur in various parts of the body. It is characterized by the presence of myofibroblastic cells, which are a type of cell involved in wound healing and tissue repair, and an inflammatory response.

Epidemiology

IMTs are rare and can occur at any age, but they are most commonly diagnosed in children and young adults. They can occur in any part of the body, but are most commonly found in the lung, abdomen, and retroperitoneum.

Pathogenesis

The exact cause of IMTs is unknown, but they are thought to be related to an abnormal response to injury or inflammation. Some studies have found that certain genetic mutations may also play a role in the development of these tumors.

Clinical Presentation

The symptoms of IMTs can vary depending on the location of the tumor. Common symptoms can include pain, swelling, and a mass that can be felt. If the tumor is in the lung, it can cause coughing, shortness of breath, and chest pain.

Diagnosis

The diagnosis of IMTs is typically made through a combination of imaging studies, such as CT scan or MRI, and a biopsy of the tumor. The biopsy can help to confirm the presence of myofibroblastic cells and inflammation.

Treatment

The main treatment for IMTs is surgical removal of the tumor. In some cases, additional treatments such as chemotherapy or radiation therapy may be used if the tumor cannot be completely removed or if it comes back after surgery.

Prognosis

The prognosis for individuals with IMTs is generally good, especially if the tumor can be completely removed. However, in some cases, the tumor can come back after treatment.

See Also

• Tumor
• Inflammation
• Myofibroblast
• Chemotherapy
• Radiation therapy

Inflammatory myofibroblastic tumor Resources
Latest articles Most recent articles Ongoing trials	Wikipedia